Literature DB >> 10477428

Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.

S E Mole1, H M Mitchison, P B Munroe.   

Abstract

The neuronal ceroid lipofuscinoses (NCLs), also referred to as Batten disease, are a group of neurodegenerative disorders characterised by the accumulation of an autofluorescent lipopigment in many cell types. Different NCL types are distinguished according to age of onset, clinical phenotype, ultrastructural characterisation of the storage material, and chromosomal location of the disease gene. At least eight genes underlie the NCLs, of which four have been isolated and mutations characterised: CLN1, CLN2, CLN3, CLN5. Two of these genes encode lysosomal enzymes, and two encode transmembrane proteins, at least one of which is likely to be in the lysosomal membrane. The basic defect in the NCLs appears to be associated with lysosomal function. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477428     DOI: 10.1002/(SICI)1098-1004(1999)14:3<199::AID-HUMU3>3.0.CO;2-A

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

Review 1.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

2.  Gene copy number variation spanning 60 million years of human and primate evolution.

Authors:  Laura Dumas; Young H Kim; Anis Karimpour-Fard; Michael Cox; Janet Hopkins; Jonathan R Pollack; James M Sikela
Journal:  Genome Res       Date:  2007-07-31       Impact factor: 9.043

3.  Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).

Authors:  Fred K Chen; Xiao Zhang; Jonathan Eintracht; Dan Zhang; Sukanya Arunachalam; Jennifer A Thompson; Enid Chelva; Dominic Mallon; Shang-Chih Chen; Terri McLaren; Tina Lamey; John De Roach; Samuel McLenachan
Journal:  Doc Ophthalmol       Date:  2018-11-16       Impact factor: 2.379

Review 4.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

5.  Astrocytes in juvenile neuronal ceroid lipofuscinosis (CLN3) display metabolic and calcium signaling abnormalities.

Authors:  Megan E Bosch; Tammy Kielian
Journal:  J Neurochem       Date:  2018-08-16       Impact factor: 5.372

Review 6.  Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis.

Authors:  Nima Naseri; Manu Sharma; Milen Velinov
Journal:  Clin Genet       Date:  2020-08-26       Impact factor: 4.438

Review 7.  The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.

Authors:  Jill M Weimer; Elizabeth Kriscenski-Perry; Yasser Elshatory; David A Pearce
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 4.103

8.  A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence.

Authors:  Amy C Flor; Don Wolfgeher; Ding Wu; Stephen J Kron
Journal:  Cell Death Discov       Date:  2017-10-30

9.  Mice deficient in the lysosomal enzyme palmitoyl-protein thioesterase 1 (PPT1) display a complex retinal phenotype.

Authors:  Yevgeniya Atiskova; Susanne Bartsch; Tatyana Danyukova; Elke Becker; Christian Hagel; Stephan Storch; Udo Bartsch
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

10.  Temporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation.

Authors:  Padmaja Tummala; Raghuveer S Mali; Eduardo Guzman; Xiao Zhang; Kenneth P Mitton
Journal:  Mol Vis       Date:  2010-02-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.